These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 22668425

  • 1. Beyond warfarin: the new generation of oral anticoagulants and their implications for the management of dental patients.
    Firriolo FJ, Hupp WS.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Apr; 113(4):431-41. PubMed ID: 22668425
    [Abstract] [Full Text] [Related]

  • 2. Acute management of bleeding in patients on novel oral anticoagulants.
    Siegal DM, Crowther MA.
    Eur Heart J; 2013 Feb; 34(7):489-498b. PubMed ID: 23220847
    [Abstract] [Full Text] [Related]

  • 3. [New anticoagulants--should we have a little bit of cold water in the blood?].
    Dyrkorn R, Roland PD.
    Tidsskr Nor Laegeforen; 2013 Feb 19; 133(4):390-1. PubMed ID: 23423204
    [No Abstract] [Full Text] [Related]

  • 4. Determination of the anti-F10a or anti-F2a generation action of rivaroxaban or dabigatran.
    Stief TW.
    Blood Coagul Fibrinolysis; 2012 Oct 19; 23(7):619-21. PubMed ID: 22821003
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Implications of Dabigatran, a direct thrombin inhibitor, for oral surgery practice.
    Davis C, Robertson C, Shivakumar S, Lee M.
    J Can Dent Assoc; 2013 Oct 19; 79():d74. PubMed ID: 23920075
    [Abstract] [Full Text] [Related]

  • 8. Practical considerations in emergency management of bleeding in the setting of target-specific oral anticoagulants.
    Miller MP, Trujillo TC, Nordenholz KE.
    Am J Emerg Med; 2014 Apr 19; 32(4):375-82. PubMed ID: 24512886
    [Abstract] [Full Text] [Related]

  • 9. [Role of new oral anticoagulants in interventional cardiology].
    Brasselet C, Duval S.
    Ann Cardiol Angeiol (Paris); 2012 Dec 19; 61(6):453-6. PubMed ID: 23102941
    [Abstract] [Full Text] [Related]

  • 10. [New anticoagulants--are we prepared?].
    Pawlikowska Z, Szponar J.
    Przegl Lek; 2012 Dec 19; 69(8):483-5. PubMed ID: 23243913
    [Abstract] [Full Text] [Related]

  • 11. [New oral anticoagulants - sunset for warfarin in therapy of atrial fibrillation].
    Koziński M, Obońska K, Kubica A, Navarese EP, Kubica J.
    Kardiol Pol; 2012 Dec 19; 70(10):1053-60. PubMed ID: 23080100
    [No Abstract] [Full Text] [Related]

  • 12. Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: guidance from the British Committee for Standards in Haematology.
    Baglin T, Keeling D, Kitchen S, British Committee for Standards in Haematology.
    Br J Haematol; 2012 Nov 19; 159(4):427-9. PubMed ID: 22970737
    [No Abstract] [Full Text] [Related]

  • 13. Drug and dietary interactions of the new and emerging oral anticoagulants.
    Walenga JM, Adiguzel C.
    Int J Clin Pract; 2010 Jun 19; 64(7):956-67. PubMed ID: 20584229
    [Abstract] [Full Text] [Related]

  • 14. [Dabigatran, a new oral anticoagulant].
    Uchiyama S.
    Brain Nerve; 2011 Apr 19; 63(4):411-5. PubMed ID: 21441645
    [Abstract] [Full Text] [Related]

  • 15. Comparing new anticoagulants.
    Wooten JM.
    South Med J; 2012 Dec 19; 105(12):665-9. PubMed ID: 23211502
    [Abstract] [Full Text] [Related]

  • 16. [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
    Dumont B, Faille D, Ajzenberg N.
    Med Sci (Paris); 2011 May 19; 27(5):493-500. PubMed ID: 21609670
    [Abstract] [Full Text] [Related]

  • 17. Importance of pharmacokinetic profile and variability as determinants of dose and response to dabigatran, rivaroxaban, and apixaban.
    Gong IY, Kim RB.
    Can J Cardiol; 2013 Jul 19; 29(7 Suppl):S24-33. PubMed ID: 23790595
    [Abstract] [Full Text] [Related]

  • 18. Clinical use of new oral anticoagulant drugs: dabigatran and rivaroxaban.
    Baglin T.
    Br J Haematol; 2013 Oct 19; 163(2):160-7. PubMed ID: 23937286
    [Abstract] [Full Text] [Related]

  • 19. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
    Mantha S, Ansell J.
    Thromb Haemost; 2012 Sep 19; 108(3):476-84. PubMed ID: 22740145
    [Abstract] [Full Text] [Related]

  • 20. New antiplatelet and anticoagulant drugs.
    Wynn RL.
    Gen Dent; 2012 Sep 19; 60(1):8-11. PubMed ID: 22313973
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.